References
- JAMA v.262 Prevalence of Alzheimer' disease in community population of older persons Evans, D.A.;Funkenstein, H.H.;Altert, M.S.;Scherr, P.A.;Cook, N.R.;Chown, M.J.;Herbert, L.E.;Hennekens, C.H.;Taylor, J.O.
- Progress Report on Alzheimer's disease (NIH Publication 95-3994) National Institute on Aging
- Arch. Neurol. v.42 Diagnosis of Alzheimer's disease Khachaturian, Z.S.
- Acta Psychiat. Scand. v.76 The prevalence of dementia: A quantitative integration of the literature Jorm, A.;Korten, A.;Henderson, A.
- Lancet v.2 Neurotransmitters and C.N.S. disease dementia Rossor, M.N.
- Exp. Neurol. v.144 Neuroprotective therapy for Parkinson's disease. Koller, W.C.
- Methods in Enzymology v.186 Role of free radicals and catalytic metal ions in human disease: an overview Halliwell, B.;Gutteridge, J.M.C.
- Free Radic. Biol. Med. v.9 Metal ion-catalyzed oxidation of proteins: biochemical mechanisms and biological consequences Stadtman, E.R.
- Lancet v.344 Oxy-radicals and cancer Cerutti, P.A.
- Pharmacol. Therapeutics v.63 Oxidative stress: free radical production in neural degeneration Gotz, M.E.;Kunig, G.;Riederer, P.;Youdim, M.B.
- Lancet v.347 Oxidative damage to DNA in diabetes mellitus Dandona, P.;Thusu, K.;Cook, S.;Snyder, B.;Makowski, J.;Armstrong, D.;Nicotera, T.
- Am. J. Pathol. v.149 Evidence fro neuronal oxidative damage in Alzheimer's disease Good, P.F.;Werner, P.;Hsu, A.;Olanow, C.W.;Perl, D.P.
- Biochem. Pharmacol. v.15 NADPH-dependent and O2-dependent lipid-peroxidation Nizamuddin, A.
- Biosci. Biotechnol. Biochem. v.58 A simple screening method for antioxidants and isolation of several antioxidants produced by marine bacteria from fish and shellfish Takao, T.;Kitatani, F.;Watanabe, N.;Yagi, A.;Sakata, K.
- Neurobiol. Disease v.7 Oxidative stress and genetics in the pathogenesis of Parkinsons disease Zhang, Y.;Dawson, V.L.;Dawson, T.M.
- J. Am. Oil Chem. Soc. v.52 Toxicology and biochemistry of butylated hydroxyanisole and butylated hydroxytoluene Branen, A.L.
- Cancer Letters v.93 Phenolic antioxidants: health protection branch studies on butylated hydroxyanisole Iverson, F.
- Med. J. Aust. v.175 Pharmacological treatment of cognitive deficits in Azheimer's disease Brodaty, H.;Ames, D.;Boundy, K.L.;Hecker, J.;Snowdon, J.;Storey, E.;Yates, M.W.
- Rev. Neurol. v.155 Alzheimer's disease: lesions and their progression Duyckaerts, C.;Colle, M.A.;Delatour, B.;Hauw, J.J.
- Arch. Neurol. v.44 Cholinesterase in cerebrosponal fluid. A longitudinal study in Alzheimer disease Elble, R.;Giavobini, E.;Scarsella, G.F.
- Science v.219 Alzheimer's disease; A disorder of cortical cholinergic innervation Coyel, J.T.;Price, D.L.;Long, M.R.
- Mechanism Aging Develop. v.122 Acetylcholinesterase in Alzheimer's disease Talesa, V.N.
- Neurobiol. Disease v.5 Possible causes of Alzheimer's disease: Amyloid fragments, free radicals, and calcium homeostasis Holscher, C.
- Drug v.53 Cognitive enhancement therapy for Alzheimer's disease The way forward Parnetti, L.;Senin, U.;Mecocci, P.
- J. Nat. Pro. v.58 Acetylcholinesterase inhibition by territrem B derivatives Peng, F.C.
- Kor. J. Pharmacogn. v.27 An acetylcholinesterase inhibitor isolated from Corydalis Tuber and its mode of action Hwang, S.Y.;Chang, Y.P.;Byun, S.J.;Jeon, M.H.;Kim, Y.C.
- Brain Res. v.760 Neuroprotective effects of the antioxidant LY231617 and NO synthase inhibitors in global cerebral ischaemia O'Neill, M.;Hicks, C.;Ward, M.;Panetta, J.A.
- Br. J. Pharmacol. v.119 Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: Antinociceptive and cardiovascular effects Handy, R.L.C.;Harb, H.L.;Wallace, P.;Gaffen, Z.;Whitehead, K.J.;Moore, P.K.
- Neuro. Sci. v.45 Monoamine oxidase B in brains from patients with Alzheimer's disease: A biochemical and autoradiographical study Jossan, S.S.;Gillberg, P.G.;Gottfries, C.G.;Karlsson, I.;Oreland, L.
- Eur. Pharmacol. Mol. Pharmacol. Sect. v.226 The molecular pharmacology of L-deprenyl Gerlach, M.;Richardson, P.;Youdim, M.B.H.
- Enzymologia v.39 Purification and properties of human brain mitochondrial monoamine oxidase Nagatsu, T.;Yamamoto, T.;Harada, M.
- Planta Med. v.22 Qualitative and quantitative evaluation of anthraquinone derivaties in Indian rhubarb Shah, C.S.;Qadry, J.S.;Bhatt, J.G.
- Biochem. Pharmacol. v.26 Substrate and inhibitor- related characteristics of human platelet monoamine oxidase Donnelly, C.H.;Murphy, D.L.
- J. Pharm. Exp. Ther. v.189 The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines Yang, H.Y.T.;Neff, N.H.
- Eur. Pharmac. Mol. Pharmacol. Sect. v.208 MPTP mechanism of neurotoxicity and their implications for Parkinson's disease Gerlach, M.;Riederer, P.;Przuntex, H.;Youdim, M.B.H.
- Science v.219 Chronic parkinsonism in human due to a product of meperidine analog synthesis Langstone, J.W.;Ballard, P.;Irwin, R.A.
- Can. J. Neurol. Sci. v.11 The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine in the monkey and man Burns, R.S.;Markey, S.P.;Phillips, J.M.;Chiueh, C.C.
- Biochem. Biophys. Res. Commun. v.120 Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase Chiba, K.;Trevor, A.;Castagnoli, N.J.
- Nature v.311 Intraneuronal generation of a pyridinium metabolic may cause drug-induced parkinsonism Markey, S.P.;Johannesse, J.N.;Chiueh, C.S.;Herkenham, M.A.
- The role of oxidative stress in the systematic toxicity of MPTP and MPP+ Adams, J.D.;Johannessen, J.H.M.;Schuller, J.P.;Bacon, S.P.;Markey, S.P.
- Free Radic. Biol. Med. v.15 MPP+ and MPDP+ induced oxygen radical formation with mitochondrial enzymes Adams, J.D.;Klaidman, L.K.;Leung, A.C.
- Synapse v.18 MPTP-induced oxidative stress and neurotoxicity are age-dependent: evidence from measures of reactive oxygen species dopamine levels Ali, S.F.;David, S.N.;Newport, G.D.;Cadet, J.L.;Slikker, W.J.
- Brain Res. v.749 Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice Sriram, K.;Pai, K.S.;Boyd, M.R.;Ravindranath, V.
- Brain Res. v.836 Oxidative stress induced by MPTP and MPP+: selective vulnerability of cultured astrocytes Wong, S.S.;Li, R.H.Y.;Stadlin, A.
- Biochem. Biophys. Res. Commun. v.128 The specific vulmerability of the substantia nigra to MPTP is related to the presence of transition metals Poirier, J.;Donaldson, J.;Barbeau, A.
- J. Neuro. Int. Soc. Neurochem. Effect of MPTP and L-Deprenyl on antioxidants enzymes and lipid peroxidation level in mouse brain Thiffault, C.;Aumont, N.;Quirion, R.;Poirier, J.
- J. Neurochem. v.57 Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain Chan, P.;Delanney, L.E.;Irwin, I.;Langston, J.W.;Monte, D.D.
- Biochem. Biophys. Res. Commun. v.135 Inhibition of mitochondrial NADH dehydrogenase by pyridine derivaties and its possible relation to experimental and idophathic Parkinsonism Ramsay, R.R.;Salach, J.I.;Dadgar, J.;Singer, T.P.
- Life Sci. v.36 Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridinium, a metabolite of the neurotoxine, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine Nicklas, W.J.;Vyas, I.;Heilkkila, R.E.
- Biochem. Biophys. Res. Comm. v.143 Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity by 1-methyl-4-phenylpyridinium ion Mizumo, Y.;Saitoh, T.;Sone, N.
- Life Sci. v.36 Selective accumulation of MPP+ in the substantia nigra: a key to neurotoxicity Irwin, I.;Langston, J.W.
- Nature v.319 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine is neurotoxic to the nigro-striatal dopamine pathway Bradbury, A.J.;Costall, B.;Domeney, A.M.;Jenner, P.;Kelly, M.E.;Marsden, C.D.;Naylor, R.J.
- J. Neurochem. v.62 Resistance of golden hamster to 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine: relationship with low levels of regional monoamine oxidase-B Mitra, M.;Mohanakumar, K.P.;Ganguly, D.K.
- Progress in Neurobiology v.60 Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases Alexi, T.;Borlongan, C.V.;Faull, R.L.M.;Williams, C.E.;Clark, R.G.;Gluckman, P.D.;Hughes, P.E.
- J. Neurochem. v.45 Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridinium ion Mytilineou, C.;Cohen, G.
- Adv. Neurol. v.45 Toxins and Parkinson's disease: MPTP parkinsonism in humans and animals Kopin, I.J.
- J. Neurochem. v.62 Oxidation products arising from the action of monoamine oxidase B on 1-methyl-4-benzyl-1,2,3,6-tetrahydropyridine, A nonneurotoxic analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Sabline, S.O.;Krueger, M.J.;Bachurin, S.O.;Solyakov, L.S.;Efange, S.M.N.;Singer, T.P.
- Movement Disorders v.14 Apomorphine protects against MPTP-induced neurotoxicity in mice Grunblatt, E.;Mandel, S.;Berkuzki, T.;Youdim, M.B.H.
- Nature v.311 Protection against the dopaminergic neurotoxicity of 1- methyl- 4- phenyl- 1,2,5,6 -tetrahydropyridine by monoamine oxidase inhibitor Heikkila R.E.;Manzino, L.;Cabbat, F.S.;Duvoisin, R.C.
- Eur. J. Pharmacol. v.106 Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys Cohen, G.;Pasik, P.;Cohen, B.;Leist, A.;Mytilineous, C.;Yahr, M.D.
- Eur. J. Pharmacol. v.306 Selegiline is neuroprotective in primary brain cultures treated with 1-methyl-4-phenylpyridinium Koutsilieri, E.;Chen, T.S.;Rausch, W.D.;Riederer, P.
- Neurosci. Letters v.224 (-)-deprenyl of 1-methyl-4-phenylpyridinium ion (MPP+) -induced apotosis independent of MAO-B inhibition Le, W.;Jankovic, J.;Xie, W.;Kong, R.;Appel, S.H.
- Brain Res. v.779 The effects of L-deprenyl treatment, alone and combined with GM1 ganglioside, on striatal dopamine content and substantia nigra pars compacta neurons Rothblat, D.S.;Schneier, J.S.
- Brain Res. v.839 7-Nitroindazole prevents 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine induced ATP loss in the mouse striatum Royland, J.E.;Delfani, K.;Langston, J.W.;Janson, A.M.;Monte, D.A.
- Parkinsonism Related Disorders v.6 MAO-B inhibitors: multiple roles in the therapy of neurodegenerative disorders? Foley, P.;Gerlach, M.;Youdim M.B.H.;Rieder, P.
- Neuropharmacol. v.39 The protective of riluzole in the MPTP model of Parkinson's disease in mice is not due to in MPP+ accumulation Boireau, A.;Dubedat, P.;Bordier, F.;Imperato, A.;Moussaou, S.
- Arch. Biochem. Biophys. v.247 Biological effects of the superoxide radical Fridovich, I.
- CRC handbook of free radical and antioxidants in biomedicine v.1 Historical introduction to free radical and antioxidant biomedical research Miquel, J.;Miquel, J.;Quintanilha, A.T.;Weber, H.(Eds.)
- FASEB J. v.9 Oxidative processes and antioxidative defense mechanism in the aging brain Reiter, R.J.
- Exp. Neurol. v.152 Brief communication azulenyl nitrone spin trap protect against MPTP neurotoxicity Klivenyi, P.;Matthews, R.;Wermer, M.;Yang, L.;MacGarvey, U. Becker, D.;Natero, R.;Beal, M.F.
- Life Sci. v.65 Involvement of monoamine oxidase inhibition in neuroprotective and neurorestorative effects of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice Wu, W.R.;Zhu, X.Z.
- Brain Res. v.864 Neuroprotection by sodium salicylate against 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity Mohankumar, K.P.;Muralikrishnan, D.;Thomas, B.
- Neuro. Aging v.21 Monoamine oxidase_B inhibitors in treatment Alzheimers disease Thomas, T.
- Neurosci. Lettters v.281 Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine in C57BL/6 mice Zou, L.L.;Xu, J.;Jankovic, J.;He, Y. Appel, S.H.;Le, W.D.
-
Free Rad. Biol. Med.
v.26
Elevation of antioxidant potency in the brain of mice by low-dose
$\gamma$ -ray irradiation and its effect on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)- induced brain damage Kojima, S.;Matsuki, O.;Nomura, T.;Yamaoka, K.;Takahashi, M.;Niki, E. - 實用中醫內科學 方藥中(主編)
- 增補 萬病回春 공廷賢
- 東洋醫學大辭典 謝觀
- 編註 醫學入門(全五卷中二) 李천
- 備急千金要方(卷四十) 孫思邈
- 中醫老年病學 袁立人
- 中藥大辭典 v.3 金昌玟;辛民敎;安德均;李京淳
- Methods Enzymol. v.234 Total antioxidant status in plasma and body fluids Rice-Evans, C.;Miller, N.J.
- Clin. Chem. Acta. v.79 Serum lipoperoxide levels in patients suffering from liver disease Suematsu, T.;Kamada, T.;Abe, H.;Kikuchi, S.;Yagi, K.
- Proc. Natl. Acad. Sci. USA. v.84 Correlation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity with blood brain barrier monoamine oxidase activity Kalaria, R.N.;Mitchell, M.J.;Harik, S.I.
- Biochem. Pharmacol. v.7 A new and rapid colorimetric determination acetylcholinesterase activity Ellman, G.L.;Coutney, K.D.;Andres, V. Jr.;Featherstone, R.M.
- J. Biol. Chem. v.193 Protein measurment with the Folin-phenol reagent Lowry, O.H.;Rosebrough, H.J.;Farr, A.L.;Randall, R.J.
- Toxicology and Applied Pharmacology v.78 Organic hydroperoxide-induced lipid peroxidation and cell death in isolated hepatocytes Rush, G.F.;Gorski, J.R.;Ripple, M.G.;Sowinski, J.;Bugelski, P.;Hewitt, W.R.
- Free Rad. Biol. Med. v.19 Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and glutathione system Benzi, G.;Moretti, A.
- Neurobiol. Aging v.16 Are reative oxygen species involved in Alzheimer's disease? Benzi, G.;Moretti, A.
- FASEB J. v.6 Relationship of resistance to oxygen free radicals to CuZn-superoxide dismutase activity in trasgenic, transfected, and trisomic cells Huang, T.T.;Carlson, E.J.;Leadon, S.A.;Epstein, C.J.
- Clin Chem v.42 Shortcomings of an automated assay for total antioxidant status in biological fluids Schofield, D.;Braganza, J.M.
- Ann. Clinical Biochem. v.35 Analytical aspects of antioxidants and free radical activity in clinical biochemistry Rumley, A.G.;Patterson, J.R.
- Annals of Clinical Biochemistry v.35 Is measuring serum antioxidant capacity clinically useful? Woodford, F.P.;Whitehead, T.P.
- Clinica Chimica Acta v.301 Comparative antioxidant potential of anaethetics and perioperative drugs in vitro Mantle, D.;Eddeb, F.;Areni, K.;Snowden, C.;Mendelow, A.D.
- J. Ethnopharmacol. v.72 Comparison of relative antioxidant activities of British medicinal plant species in vitro Mantle, D.;Eddeb, F.;Pickering, A.T.
- Phytochem. v.26 Hydroxyl radical scavenging activity of flavonoids Husain, S.R.;Cillard, J.;Cillard, P.
- Neurotoxicol. Teratology v.22 Age- related changes in reactive oxygen species production in rat brain homogenates Driver, A.S.;Kodavanti, P.R.S.;Mundy, W.R.
- J. Environ. Health v.8 Effective human cancer prevention as goal for the regulation of environmental chemicals Weisburger, J.H.
- Food Sci. Technol. International v.6 The contribution of plant food antioxidants to human health Ramarathnam, N.;Osawa, T.;Ochi, H.;Kawakishi, S.
- Journal of Cereal Science v.33 Oat antioxidants Peterson, D.M.
- 韓方成人病學會誌 v.3 三和散이 腦組織의 acetylcholine esterase 및 monoamine oxidase 活性에 미치는 影響 徐榮浚;申鉉喆;尹哲浩;鄭智天;申億變
- 東醫神經精神科學會誌 v.8 七福飮이 노화 백서 뇌조직의 생화학적 변화에 미치는 영향 손정석;류영수
- 大韓韓醫學會誌 v.19 定志丸이 腦組織의 生化學的 變化와 神經細胞의 損傷에 미치는 實驗的 硏究 崔龍埈;成彊慶;文炳淳
- J. Neurochem. v.46 Monoamine oxidase activity and monoamine metabolism in brains of Parkinsonianpatients treated with L-deprenyl Riederer, P.;Youdim, M.B.H.
- Life Sci. v.28 The concurrent estimation of the major monoamine metabolites in human and non-human primate brain by HPLC with fluorescence and electrochemical detection Cross, A.J.;Joseph, M.H.
- Life Sci. v.40 Quinoline and quinaldine as naturally occurring inhibitors specific for type A monoamine oxidase Naoi, M.;Nagatsu, T.
- Biochem. Pharmacol. v.47 Screening of unsubstituted cyclic compounds as inhibitors of monoamine oxidases Thull, U.;Testa, B.
- J. Kor. Soc. Agric. Chem. Biotechnol. v.42 Isolation of monoamine oxidase B inhibitory compound from the leaves of Eucommia ulmoides Baek, N.-I.;Ahn, E.-M.;Hahn, J.-T.;Lee, D.W.;Sohn, H.O.;Kwon, B.-M.
- Food Sci. Biotechnol. v.9 Phenolics with inhibitory activity on mouse brain monoamine oxidase (MAO) from whole parts of Artemisia vulgaris L (Mugwort) Lee, S.-J.;Chung, H.-Y.;Lee, I.-K.;Oh, S.-U.;Yoo, I.-D.
- Kor. J. Pharmacogn. v.28 Screening of the acetylcholinesterase inhibitors from medicinal plants Lee, B.H.;Choi, B.W.;Ryu, G.S.;Lee, E.S.;Kang, K.J.;Hwang, D.Y.;Hong, N.D.
- J. Neural. Transm. no.Sup. 32 Kinetic evaluation of MAO-B activity following oral administration of selegiline and desmethyl-selegiline in the rat Borbe, H.O.;Niebch, G.;Nickel, B.
- J. Clin. Psychiatry v.44 Pargyline-induced mania in primary affective disorder: case report Folks, D.;Arnold, E.S.
- Exp. Neurology v.158 Spontaneaus blink rates correlate with dopamine levels in the caudate nucleus of MPTP-treated monkeys Taylor, J.R.;Elsworth, J.D.;Lawrence, M.S.;Sladek, J.R.;Roth, R.H.;Redmond, D.E.
- Eur. J. Pharmocol. v.124 Comparative toxicity of MPTP, MPP+ and 3,3- dimethyl-MPDP+ to dopaminergic neurons of the rat substantia nigra Sayre, L.M.;Arora, P.K.;Iacofano, L.A.;Harik, S.I.
- J. Neurochem. v.58 MK-81 fail to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridium in rats Sonsalla, P.K.;Zeevalk, G.D.;Manzino, L.;Giovanni, A.;Nicklas, W.J.
- Exp. Neurology v.126 Difference in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/BL and CD-1 mice Muthane, U.;Ramsay, K.A.;Jiang, H.;Jackson-Lewis, V.;Donaldson, D.;Fernando, S.;Ferreira, M.;Prezedborski, S.
- Human Exp. Toxicol. v.15 No changes in behavior, nigro-striatal system neurochemistry or neuronal cell death following toxic multiple oral paraquat administration to rats Widdowson, P.S.;Farnworth, M.J.;Upton, R.;Simpson, M.G.
- Naunyn. Schmiedebergs. Arch. Pharmacol. v.353 Effects of nicotine on hydroxyl free radical formation in vitro and on MPTP-induced neurotoxicity in vivo Ferger, B.;Spratt, C.;Earl, C.D.;Teismann, P.;Oertel, W.H.;Kuschinsky, K.
- Proc. Soc. Exp. Biol. Med. v.193 Mechanism of food restriction: Protection of cellular homeostasis Yu, B.P.;Lee, D.W.;Marler, C.G.;Choi, J.H.
- Free Rad. Biol. Med. v.24 MPTP produces differential oxidative stress and antioxidative responses in the nigrostriatal and mesolimbic dopaminergic pathways Hung, H.C.;Lee, E.H.Y.
- Eur. J. Pharmacol. v.166 1-methyl-4-phenylpyridinium (MPP+) analogs: in vivo neurotoxicity and inhibition of striatal synaptosomal dopamine uptake Johnson, E.A.;Wu, E.Y.;Rollema, H.;Booth, R.G.;Trevor, A.J.;Castagnoll, N.
- Pharm. Toxicol. v.67 The neurotoxicity and the relevance to Parkonson's disease Mccrodden, J.M.;Tipton, K.F.;Sullivan, J.P.
- J. Pharmacol. Exp. Ther. v.291 Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4- phenyl-1,2,3,6- tetrahydropyridinyl derivatives Inoue, H.;Castagnoli, K.;van der Schyf, C.;Mabic, S.;Igarashi, K.;Castagnoli, N.Jr.
- In advances in neurology Birkmayer, W.;Riederer, P.;Rausch, W.D.;Poirier, L.H.;Sourkes, T.L.;Bedard, J.P.(Eds.)
- Treatment of Depression, Old Controversis and New Approaches Paykel, E.S.;Rowan, P.R.;Rao, B.M.;Bhat, A.;Cayton, P.J.;Barnett, J.E.(Eds.)